ATLAS / Macro Radar / Reporting / XENE

Xenon Pharmaceuticals Inc. (XENE) reporting calendar

Xenon Pharmaceuticals Inc. files periodic reports with the SEC as XENE on Nasdaq. Atlas tracks 47 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
30 Jul 2026 – 23 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
47

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 42 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open XENE market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001193125-26-212153
10-K31 Dec 202526 Feb 202657 days0001193125-26-076650
10-Q30 Sep 20253 Nov 202534 days0001193125-25-262646
10-Q30 Jun 202511 Aug 202542 days0000950170-25-106599
10-Q31 Mar 202512 May 202542 days0000950170-25-069342
10-K31 Dec 202427 Feb 202558 days0000950170-25-029149
10-Q30 Sep 202412 Nov 202443 days0000950170-24-125547
10-Q30 Jun 20248 Aug 202439 days0000950170-24-094109
10-Q31 Mar 20249 May 202439 days0000950170-24-057139
10-K31 Dec 202329 Feb 202460 days0000950170-24-023177
10-Q30 Sep 20238 Nov 202339 days0000950170-23-061200
10-Q30 Jun 20239 Aug 202340 days0000950170-23-040681
10-Q31 Mar 20239 May 202339 days0000950170-23-019775
10-K31 Dec 20221 Mar 202360 days0000950170-23-005582
10-Q30 Sep 20228 Nov 202239 days0000950170-22-023283
10-Q30 Jun 20229 Aug 202240 days0001564590-22-028780
10-Q31 Mar 202210 May 202240 days0001564590-22-019318
10-K31 Dec 20211 Mar 202260 days0001564590-22-008060
10-Q30 Sep 202110 Nov 202141 days0001564590-21-056248
10-Q30 Jun 202111 Aug 202142 days0001564590-21-043484
10-Q31 Mar 202111 May 202141 days0001564590-21-026590
10-K31 Dec 20201 Mar 202160 days0001564590-21-009905
10-Q30 Sep 20205 Nov 202036 days0001564590-20-051443
10-Q30 Jun 20206 Aug 202037 days0001564590-20-037862
10-Q31 Mar 202021 May 202051 days0001564590-20-026574
10-K31 Dec 20199 Mar 202069 days0001564590-20-009385
10-Q30 Sep 20195 Nov 201936 days0001564590-19-040449
10-Q30 Jun 20196 Aug 201937 days0001564590-19-029418
10-Q31 Mar 20197 May 201937 days0001564590-19-016580
10-K31 Dec 20186 Mar 201965 days0001564590-19-006514
10-Q30 Sep 20186 Nov 201837 days0001564590-18-027475
10-Q30 Jun 20187 Aug 201838 days0001564590-18-020018
10-Q31 Mar 20188 May 201838 days0001564590-18-011901
10-K31 Dec 20177 Mar 201866 days0001564590-18-004750
10-Q30 Sep 20177 Nov 201738 days0001564590-17-022348
10-Q30 Jun 20173 Aug 201734 days0001564590-17-015414
10-Q31 Mar 20179 May 201739 days0001564590-17-009917
10-K31 Dec 20168 Mar 201767 days0001564590-17-003716
10-Q30 Sep 20163 Nov 201634 days0001564590-16-027414
10-Q30 Jun 20163 Aug 201634 days0001564590-16-022390

Source: SEC EDGAR company submissions for CIK 0001582313. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.